Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Plos Medicine|July 18, 2022
Prevention of venous thromboembolic events in patients with lower leg immobilization after trauma: Systematic review and network meta-analysis with meta-epsidemiological approachD Douillet, C Chapelle, E Ollier, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2013
Consistency of safety profile of new oral anticoagulants in patients with renal failureJ-C Lega, L Bertoletti, C Gremillet, et al.
Journal of Pharmaceutical Sciences|February 25, 2000
Inter-study variability in population pharmacokinetic meta-analysis: when and how to estimate it?S Laporte-Simitsidis, P Girard, P Mismetti, et al.
British Journal of Clinical Pharmacology|June 8, 2018
Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time-to-event analysisP J Zufferey, E Ollier, X Delavenne, et al.
Journal of Thrombosis and Haemostasis : JTH|May 11, 2013
Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysisJ-C Lega, P Mismetti, M Cucherat, et al.
Pharmacopsychiatry|July 24, 2012
Antipsychotics: a real or confounding risk factor for venous thromboembolism?C Chapelle, S Quenet, X Delavenne, et al.
British Journal of Clinical Pharmacology|May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years oldA Berges, S Laporte, M Epinat, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Circadian dynamics of coagulation and chronopathology of cardiovascular and cerebrovascular events. Future therapeutic implications for the treatment of these disorders?H Decousus, C Boissier, B Perpoint, et al.
Fundamental & Clinical Pharmacology|March 10, 2009
Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acidX Delavenne, S Laporte, S Demasles, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancerG Simonneau, S Laporte, P Mismetti, et al.
Pageof 14